Production of TNF alpha, IL-1, IL-6 and nitric oxide by isolated human islets.
Vara
E
E
Department of Biochemistry, Facultad de Medicina, (Hospital San Carlos), Universidad Complutense, Madrid, Spain.
Arias-Díaz
J
J
García
C
C
Hernández
J
J
García-Carreras
C
C
Cuadrado
A
A
Balibrea
J L
JL
D000911:Antibodies, Monoclonal / Q000494:pharmacology; D006152:Cyclic GMP / Q000378:metabolism; D016207:Cytokines / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D006801:Humans; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007375:Interleukin-1 / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000494:pharmacology; D015850:Interleukin-6 / Q000096:biosynthesis; D007515:Islets of Langerhans / Q000187:drug effects / Q000276:immunology* / Q000502:physiology*; D008070:Lipopolysaccharides / Q000494:pharmacology; D009569:Nitric Oxide / Q000096:biosynthesis*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D000093242:Interleukin-6 Inhibitors
D000911:Antibodies, Monoclonal; D006152:Cyclic GMP; D016207:Cytokines; D007328:Insulin; D007375:Interleukin-1; D015850:Interleukin-6; D008070:Lipopolysaccharides; D009569:Nitric Oxide; D014409:Tumor Necrosis Factor-alpha; D000093242:Interleukin-6 Inhibitors